The BsAbs simultaneously bind to a tumor antigen BCMA or GPRC5D expressed on myeloma cells and to CD3 on the T cells, resulting in the redirection of T cells to myeloma cells with subsequent T cell activation, leading to tumor cell death [100]. The gene discussed is TNFRSF17; the disease is plasma cell myeloma.